Moderna ( MRNA ) Beats Stock Market Upswing: What Investors Need to Know
Moderna (MRNA) concluded the recent trading session at $28.38, signifying a +2.83% move from its prior day's close.
Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency?
Moderna plans up to 10 product launches over four years, aiming to cut reliance on fading COVID-19 vaccine sales.
Moderna ( MRNA ) Recently Broke Out Above the 50-Day Moving Average
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
Moderna Stock Is Rallying Wednesday: What's Driving The Action? - Moderna ( NASDAQ:MRNA )
Moderna Inc ( NASDAQ:MRNA ) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc ( NYSE:PFE ) and the Trump administration to lower prescription drug prices.
2 Beaten-Down Stocks to Buy and Hold for a Decade
These biotechs should benefit from their innovative ways.
Moderna ( MRNA ) Dips More Than Broader Market: What You Should Know
In the closing of the recent trading day, Moderna (MRNA) stood at $24.61, denoting a -4.91% move from the preceding trading day.
Flagship Pioneering, Creator Of Moderna, Launches Extuitive With $20M To Reinvent Consumer Products Using AI Shoppers - Moderna ( NASDAQ:MRNA )
Flagship Pioneering, the Cambridge venture firm known for creating Moderna MRNA, last Thursday unveiled a new startup called Extuitive with $20 million in seed funding.
Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows - Moderna ( NASDAQ:MRNA )
Moderna Inc. MRNA on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE ( COVID-19 Vaccine, mRNA ) , which targets the LP.8.1 variant of SARS-CoV-2.
Is Moderna Gaining or Losing Market Support? - Moderna ( NASDAQ:MRNA )
Moderna's MRNA short interest as a percent of float has fallen 4.79% since its last report. According to exchange reported data, there are now 59.84 million shares sold short, which is 21.49% of all regular shares that are available for trading.
Will the FDA's Nod for Subcutaneous Keytruda Ease Merck's Headwinds?
FDA clears MRK's Keytruda Qlex, a subcutaneous option that promises faster treatment and new patent protection amid looming headwinds.
RFK Jr.'s vaccine panel weakens Covid shot recommendations, calling it an individual decision
The group also voted to emphasize that the Covid vaccine is beneficial for those at high risk of severe illness from the disease.
PHILLIPS TO PRESENT VISUAL LANGUAGE: THE ART OF IRVING PENN, A LANDMARK AUCTION IN PARTNERSHIP WITH THE IRVING PENN FOUNDATION
Unprecedented Sale and Exhibition in October to Feature 70 Works of Exceptional Provenance and Significance NEW YORK, Sept. 19, 2025 /PRNewswire/ -- This fall, Phillips will host Visual Language: The Art of Irving Penn, a landmark auction of works from The Irving Penn Foundation.
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' - Dynavax Technologies ( NASDAQ:DVAX ) , GSK ( NYSE:GSK )
Sen. Elizabeth Warren ( D-Mass. ) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.
Moderna ( MRNA ) Outpaces Stock Market Gains: What You Should Know
In the most recent trading session, Moderna (MRNA) closed at $25.51, indicating a +2.03% shift from the previous trading day.
Covid shot access, coverage at stake as RFK Jr.'s hand-picked vaccine panel convenes
Some experts warn that weakening recommendations for Covid vaccines and other shots could make it harder for some people to access jabs and have them covered.
What's Going On With Moderna Stock Wednesday? - Moderna ( NASDAQ:MRNA )
Moderna shares are trading marginally lower Wednesday morning. Tuesday's rally was driven by the release of positive preliminary data for its updated 2025-2026 Spikevax formula. See the trading strategy with a perfect track record in 2025 [currently 34-0] →
MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response
Moderna jumps after its updated formulation of Spikevax shows an over 8-fold increase in neutralizing antibodies against the LP.8.1 COVID-19 variant in phase IV study.
Vertex Plunges Around 24% in Six Months: How to Play the Stock
Vertex shares fall nearly 24% in six months on pipeline setbacks but strong CF sales and new launches may shape the future.
Moderna Stock Is Moving Higher Tuesday: Here's Why - Moderna ( NASDAQ:MRNA )
Moderna announces positive preliminary immunogenicity data for its 2025-2026 Spikevax formula. Moderna shares are up close to 5% at the time of writing. Want to trade this news? Get access to the 34-0 income strategy that loves volatility → Moderna, Inc.
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax - Moderna ( NASDAQ:MRNA )
The vaccine boosted neutralizing antibodies by over 8 times in adults 65+ and those with underlying conditions. No new safety concerns were found; the vaccine aligns with top COVID strains like LP.8.1, XFG, and NB.1.8.1. Up Next: Wall Street trader's 34-0 strategy goes public this week.
Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots - Merck & Co ( NYSE:MRK ) , GSK ( NYSE:GSK )
Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, just days before it reconvenes to vote on COVID-19 shots and other routine pediatric vaccine recommendations.
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths
MRNA, BNTX, PFE and NVAX stocks fall as health officials reportedly plan to link COVID-19 vaccines to child deaths ahead of a key CDC meeting.
Moderna ( MRNA ) Declines More Than Market: Some Information for Investors
Moderna (MRNA) reached $23.51 at the closing of the latest trading day, reflecting a -7.4% change compared to its last close.
Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths - Moderna ( NASDAQ:MRNA ) , Pfizer ( NYSE:PFE ) , BioNTech ( NASDAQ:BNTX )
Shares of COVID-19 vaccine makers are trading lower Friday. Vaccine stocks fell Friday on a Washington Post report that Trump administration officials plan to link the shots to 25 child deaths. Want to trade this news? Get access to the 34-0 income strategy that loves volatility →
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
The report says officials plan to include the claim in a presentation next week to a key vaccine panel that advises the CDC on shot access and coverage.
Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock?
Merck stock is down 14% this year as Keytruda-led growth gets offset by Gardasil weakness and looming patent risks, which cloud the outlook.
FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects - Novavax ( NASDAQ:NVAX ) , Moderna ( NASDAQ:MRNA ) , Pfizer ( NYSE:PFE )
FDA seeks to lift privacy rules on Covid vaccine data for pregnant women to reveal more potential side effects. Pfizer, Moderna and Novavax defended their vaccines after Trump's transparency call, citing safety data for pregnant women. Get the data-driven signals to profit from September ...
Is it Time to Dump Your Shares of Moderna?
Moderna is working with advanced technology to help transform the way medicines are created, but is that enough reason to stick around?
RFK Jr. spreads vaccine misinformation during congressional testimony
Kennedy said he supports a statement made by a newly appointed member of a key government vaccine panel that mRNA vaccines pose a dangerous risk to people.
3 Things You Need to Know if You Buy Pfizer Today
Pfizer has a lofty 6.9% dividend yield, but is it the only or best choice for investors interested in the pharma space?
Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster' - Merck & Co ( NYSE:MRK ) , GSK ( NYSE:GSK )
Florida plans to end all statewide vaccine mandates, even those required for school attendance, framing the move as a defense of individual liberties, which has since received pushback from public health experts.
Trump Demands Pfizer, Other Covid Drug Makers To 'Justify The Success,' Show Their Results Amid New FDA Restrictions-'Clear Up This Mess' - Moderna ( NASDAQ:MRNA ) , Pfizer ( NYSE:PFE )
President Donald Trump has called for pharmaceutical companies to provide evidence of the effectiveness of their COVID-19 drugs. Trump took to his social media platform, Truth Social, on Monday and called on drug companies to 'Justify the success' and disclose their results more openly, stating ...
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works - Moderna ( NASDAQ:MRNA ) , BioNTech ( NASDAQ:BNTX )
Former Centers for Disease Control and Prevention immunizations chief Demetre Daskalakis said Sunday he resigned because politics has overrun science at the nation's top public-health agency, warning he "only see[s] harm coming" under Health and Human Services Secretary Robert F. Kennedy Jr.
Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepens - Merck & Co ( NYSE:MRK ) , GSK ( NYSE:GSK )
Senator Bernie Sanders ( I-VT ) called for Health and Human Services Secretary Robert F. Kennedy Jr.'s resignation on Saturday, citing Kennedy's "dangerous policies" that are "endangering the health of the American people."
Boyd Gaming and Shoe Carnival have been highlighted as Zacks Bull and Bear of the Day
Boyd Gaming surges on strong earnings and growth plans, while Shoe Carnival struggles with sliding sales and weaker momentum.
FDA Approves Updated COVID-19 Vaccines but With Restrictions
FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups.
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines - Novavax ( NASDAQ:NVAX ) , Moderna ( NASDAQ:MRNA ) , Pfizer ( NYSE:PFE ) , BioNTech ( NASDAQ:BNTX )
FDA approves updated Pfizer, Moderna, and Novavax Covid vaccines for high-risk individuals. Pfizer-BioNTech Covid vaccine doses exceed 5 billion distributed globally. The market is reacting to NVIDIA's earnings. Learn how to time your next trade here → Health and Human Services Secretary Robert ...
FDA ends broad Covid vaccine authorization as RFK Jr. limits access to immunizations
It's unclear how easily patients without high risk factors will be able to get a Covid shot, and whether insurance plans will still cover them.
David Gardner on "Rule Breaker Investing"
A book ready for pre-order and ideas aplenty to discuss.
Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months' - Moderna ( NASDAQ:MRNA ) , BioNTech ( NASDAQ:BNTX )
RFK Jr.'s adviser says COVID-19 vaccines could be pulled from the U.S. market within months. MIT professor critical of mRNA shots named to lead federal vaccine task force. See the seasonal trading strategy that's beating the S&P 500 by 6X this year. Details here →
Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now?
EXEL rides on Cabometyx momentum and pipeline gains, while MRK leans on Keytruda dominance and a diverse portfolio for growth.
Stock Market Today: Nasdaq 100, Dow Futures Fall After Friday's Rally-Intel, PDD, Keurig Dr Pepper In Focus - SPDR S&P 500 ( ARCA:SPY )
U.S. stock futures fell on Monday following Friday's advances. Futures of major benchmark indices were lower. On Friday, Federal Reserve Chair Jerome Powell gave Wall Street-and Main Street-a reason to celebrate.
Moderna Stock Is Trading Higher Friday: What's Going On? - Moderna ( NASDAQ:MRNA )
Health Canada approves Moderna's updated Spikevax vaccine targeting the LP.8.1 variant for individuals six months and older. All pre-filled syringe doses for Canada are produced domestically for the first time, with Canadian-made supply available this fall. The market is reacting to Powell's ...
Can Keytruda Sustain Merck's Growth Through the Rest of 2025?
MRK banks on Keytruda's soaring sales and new oncology strategies to fuel 2025 growth, even as competition and patent loss loom.
If You're in Your 30s, Consider Buying These 2 Healthcare Stocks
Both companies have helped pioneer important medical breakthroughs.
UnitedHealth's Best Day Since 2008, Intel's Best Week Since 1975 - SPDR S&P 500 ( ARCA:SPY )
Major U.S. indices ease from record highs as investors awaited the Trump-Putin meeting and digested weaker consumer sentiment. Dow Jones gained 0.2% above 45,000, lifted by a pharma rally led by UnitedHealth's 14% jump on Berkshire Hathaway stake.
Vaxart Revenue Jumps 520% in Fiscal Q2
Vaxart ( OTC:VXRT ) , a biotechnology company focused on developing oral tablet vaccines for infectious diseases, reported its second quarter results on August 13, 2025. The standout headline was a revenue surge to $39.7 million ( GAAP ) -well above the $2.03 million analyst consensus-driven by a ...
Moderna Options Trading: A Deep Dive into Market Sentiment - Moderna ( NASDAQ:MRNA )
Investors with a lot of money to spend have taken a bullish stance on Moderna MRNA. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.
Gauzy Ltd. Announces Second Quarter 2025 Results
Record Backlog Purchase Orders of $42.9 Million at Quarter End ...
Immatics Announces Second Quarter 2025 Financial Results and Business Update
Houston, Texas and Tuebingen, Germany, August 13, 2025 - Immatics N.V. ( NASDAQ: IMTX, "Immatics" or the "Company" ) , a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today provided a business update and reported financial results for the quarter ...
